(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe...
Stats | |
---|---|
Šios dienos apimtis | 5 872.00 |
Vidutinė apimtis | 7 158.00 |
Rinkos kapitalizacija | 67.47M |
EPS | $0 ( 2024-04-04 ) |
Kita pelno data | ( $-0.350 ) 2024-05-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.50 |
ATR14 | $0 (0.00%) |
Collplant Biotechnologies Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
NETE | 0.965 |
CPTN | 0.964 |
QRTEA | 0.964 |
PRCH | 0.96 |
RAVN | 0.953 |
PRAX | 0.953 |
AADI | 0.949 |
CDNA | 0.949 |
CYCC | 0.948 |
ICCC | 0.948 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
PAIC | -0.973 |
SVAC | -0.948 |
SGEN | -0.939 |
TIG | -0.937 |
ORTX | -0.925 |
CCRC | -0.914 |
PPYAU | -0.912 |
DNUT | -0.905 |
TLGT | -0.903 |
BTBD | -0.902 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Collplant Biotechnologies Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $10.96M |
Bruto pelnas: | $7.87M (71.78 %) |
EPS: | $-0.620 |
FY | 2023 |
Pajamos: | $10.96M |
Bruto pelnas: | $7.87M (71.78 %) |
EPS: | $-0.620 |
FY | 2022 |
Pajamos: | $299 000 |
Bruto pelnas: | $-101 000 (-33.78 %) |
EPS: | $-1.520 |
FY | 2021 |
Pajamos: | $15.64M |
Bruto pelnas: | $13.64M (87.18 %) |
EPS: | $0.0200 |
Financial Reports:
No articles found.
Collplant Biotechnologies
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.